Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Miyazaki

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Japanese Journal of Clinical Oncology|December 15, 2015
Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experienceEiji Kikuchi, Jun Miyazaki, Kazuyuki Yuge, et al.
Clinical and Experimental Nephrology|August 28, 2016
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patientsRyutaro Ishitsuka, Jun Miyazaki, Daishi Ichioka, et al.
BMC Cancer|March 16, 2018
A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional studyTakamitsu Inoue, Jun Miyazaki, Daishi Ichioka, et al.
International Journal of Clinical Oncology|June 29, 2016
Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study)Yoshiyuki Matsui, Osamu Ogawa, Ryutaro Ishitsuka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 29, 2016
[Solitary Bladder Metastasis of Chromophobe Renal Cell Carcinoma: Report of a Case]Satoshi Nitta, Takahiro Suetomi, Kousuke Kojou, et al.
Plos One|August 2, 2019
TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancerTakashi Kawahara, Takahiro Kojima, Shuya Kandori, et al.
BMC Urology|December 29, 2019
The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational studyJun Miyazaki, Mizuki Onozawa, Satoshi Takahashi, et al.
Cancer Reports (Hoboken, N.J.)|June 17, 2026
Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based CombinationsHiromichi Sakurai, Masanobu Shiga, Shuya Kandori, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 25, 2025
The fourth nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2021Mitsuru Yasuda, Satoshi Takahashi, Saori Oba, et al.
Scientific Reports|August 21, 2025
A novel, synthesized, amphiphilic ethylene glycol squalene derivative suppresses BBN-induced bladder carcinogenesisKeisuke Sano, Masanobu Shiga, Farhana Ferdousi, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Japanese Journal of Clinical Oncology|December 15, 2015
Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experienceEiji Kikuchi, Jun Miyazaki, Kazuyuki Yuge, et al.
Clinical and Experimental Nephrology|August 28, 2016
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patientsRyutaro Ishitsuka, Jun Miyazaki, Daishi Ichioka, et al.
BMC Cancer|March 16, 2018
A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional studyTakamitsu Inoue, Jun Miyazaki, Daishi Ichioka, et al.
International Journal of Clinical Oncology|June 29, 2016
Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study)Yoshiyuki Matsui, Osamu Ogawa, Ryutaro Ishitsuka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 29, 2016
[Solitary Bladder Metastasis of Chromophobe Renal Cell Carcinoma: Report of a Case]Satoshi Nitta, Takahiro Suetomi, Kousuke Kojou, et al.
Plos One|August 2, 2019
TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancerTakashi Kawahara, Takahiro Kojima, Shuya Kandori, et al.
BMC Urology|December 29, 2019
The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational studyJun Miyazaki, Mizuki Onozawa, Satoshi Takahashi, et al.
Cancer Reports (Hoboken, N.J.)|June 17, 2026
Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based CombinationsHiromichi Sakurai, Masanobu Shiga, Shuya Kandori, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 25, 2025
The fourth nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2021Mitsuru Yasuda, Satoshi Takahashi, Saori Oba, et al.
Scientific Reports|August 21, 2025
A novel, synthesized, amphiphilic ethylene glycol squalene derivative suppresses BBN-induced bladder carcinogenesisKeisuke Sano, Masanobu Shiga, Farhana Ferdousi, et al.
Pageof 17